Interleukin-2 and Interferon- α for Advanced Renal Cell Carcinoma: Patient Outcomes, Sexual Dimorphism of Responses, and Multimodal Treatment Approaches over a 30-Year Period

Conclusions: We provide evidence that IT with s.c. IL-2 and IFN- α played a vital role in long-term survivors either by inducing lasting complete remissions or as part of multimodal approaches that allowed patients to survive until novel therapies became available. The implications for current immune oncological treatment approaches are being discussed.Urol Int
Source: Urologia Internationalis - Category: Urology & Nephrology Source Type: research